ArticleEuropean journal of pediatrics2026
Malrotation after infancy-can we do better? A 10-year multi-centre retrospective review.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malrotation is classically a neonatal condition, but it can present in older children. This population has a non-specific presentation that can delay diagnosis with fatal consequences. We aimed to identify presentation patterns and efficacy of imaging modalities to inform the management of children with suspected malrotation. Children aged 1-18 who had surgery for malrotation between 2014 and 2024 at four centres in the south of England were retrospectively reviewed. Hospital presentations, radiology, operative findings and outcomes were reviewed. Seventy-five. patients were identified: 35 (47%) had emergency surgery, and 40 (53%) had elective surgery. The median symptom onset was 3 years (IQR 1.0-6.0). The median age at hospital presentation was 4.9 (IQR 3.4-7.9), and the median age at surgery was 6 years (IQR 2.7-9.9). The median time from presentation to surgery was 1.9 years in the emergency group and 1 year in the elective group (p = 0.18). Common symptoms were abdominal pain (69%), vomiting (52%) and bilious vomiting (27%). Sixty-three percent of emergency patients had prior presentations. Upper-GI contrast (UGI) was the most common radiological study (72%; sensitivity (SN), 89%; false negative rate, (FNR) 3.7%). Ultrasound was used in 33% of cases (SN, 56%; FNR, 44%). Cross-sectional imaging was used in 20% of cases: eleven CT scans (SN, 81%; FNR, 0.0%) and four MRI scans (SN, 50%; FNR, 0.0%). Of the three mortality and nine bowel ischaemia cases, 67% had presented previously.
conclusionOur cohort demonstrated delays between presentation and surgery. Malrotation must be considered in cases of recurrent abdominal pain or vomiting. USS is not reliable in this cohort. We recommend these children undergo UGI or cross-sectional imaging to exclude malrotation. Timely diagnosis and intervention will prevent morbidity and mortality. WHAT IS KNOWN: • Malrotation in older children is known to have a less specific presentation than classical neonatal malrotation associated with bilious vomiting. This can delay diagnosis and intervention. WHAT IS NEW: • This would be the largest cohort in the European literature comprehensively reporting presentations, investigations and outcomes for children with malrotation over the age of 1 year. In providing this information, our study helps clinicians identify patients in need of investigation for malrotation and what investigations can be relied upon in this context. This should help provide timely investigation and management of these children, reducing their risk of morbidity and mortality.
Indexed as
Identifiers
41925936What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.